Click on a filter below to refine your search. Remove a filter to broaden your search.
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Nighttime light exposure was more strongly linked to AD prevalence than any other disease factor among those younger than 65 years.
A lower rate of amyloid-β plasma biomarker positivity was seen in multiple sclerosis patients compared with non-MS controls.
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
The findings were seen in a large study of older veterans with diabetes.
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.
The diagnostic accuracy 73% for dementia specialists compared with 91% using the APS2.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.